Sumitomo Dainippon Seeks Japanese Approval for Trerief to Treat Parkinsonism in Dementia Patients
Sumitomo Dainippon Pharma has asked Japanese authorities to approve its Trerief (zonisamide) as a new therapy for parkinsonism in dementia…
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Sumitomo Dainippon Pharma has asked Japanese authorities to approve its Trerief (zonisamide) as a new therapy for parkinsonism in dementia…
The biopharmaceutical company Cavion announced the appointment of a new executive vice president of research and development and chief medical…
The Parkinson’s Foundation will award $1.2 million to early career scientists working on Parkinson’s disease research in 27 new…
The United States is just four days away from sending a SpaceX rocket to the International Space Station whose cargo will…
The Parkinson’s Foundation has started a podcast series on new research findings, advice for those with the disease and their families,…
Peter Istvan and David Newall founded “Pedaling for Parkinson’s” in 2011 as an annual cycling fundraising event to support…
The cognitive science company Cogstate received approval to market a new digital cognitive assessment tool to assist healthcare professionals in measuring cognition…
Acadia Pharmaceuticals, the maker of Nuplazid (pimavanserin), an oral medication to treat hallucinations and delusions associated with…
Hong Kong has issued a patent to Intec Pharma for its investigational Accordion Pill Carbidopa/Levodopa (AP-CD/LD) drug delivery for Parkinson’s…
The Parkinson’s Disease Digital Biomarker DREAM Challenge was just launched by Sage Bionetworks as the first of a…
Get regular updates to your inbox.